{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T02:10:14Z","timestamp":1768011014882,"version":"3.49.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2012,4,11]],"date-time":"2012-04-11T00:00:00Z","timestamp":1334102400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Forensic Toxicol"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1007\/s11419-012-0136-7","type":"journal-article","created":{"date-parts":[[2012,4,10]],"date-time":"2012-04-10T09:07:11Z","timestamp":1334048831000},"page":"114-125","source":"Crossref","is-referenced-by-count":113,"title":["Identification of two new-type synthetic cannabinoids, N-(1-adamantyl)-1-pentyl-1H-indole-3-carboxamide (APICA) and N-(1-adamantyl)-1-pentyl-1H-indazole-3-carboxamide (APINACA), and detection of five synthetic cannabinoids, AM-1220, AM-2233, AM-1241, CB-13 (CRA-13), and AM-1248, as designer drugs in illegal products"],"prefix":"10.1007","volume":"30","author":[{"given":"Nahoko","family":"Uchiyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maiko","family":"Kawamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruri","family":"Kikura-Hanajiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yukihiro","family":"Goda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2012,4,11]]},"reference":[{"key":"136_CR1","unstructured":"EMCDDA (2009) EMCDDA action on new drugs briefing paper: understanding the \u2018Spice\u2019 phenomenon (a report from an EMCDDA expert meeting, 6 March 2009, Lisbon). http:\/\/www.emcdda.europa.eu\/attachements.cfm\/att_80086_EN_Spice%20Thematic%20paper%20\u2014%20final%20version.pdf . Accessed April 2010"},{"key":"136_CR2","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1248\/cpb.57.439","volume":"57","author":"N Uchiyama","year":"2009","unstructured":"Uchiyama N, Kikura-Hanajiri R, Kawahara N, Haishima Y, Goda Y (2009) Identification of a cannabinoid analog as a new type of designer drug in a herbal product. Chem Pharm Bull 57:439\u2013441","journal-title":"Chem Pharm Bull"},{"key":"136_CR3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11419-009-0069-y","volume":"27","author":"N Uchiyama","year":"2009","unstructured":"Uchiyama N, Kikura-Hanajiri R, Kawahara N, Goda Y (2009) Identification of a cannabimimetic indole as a designer drug in a herbal product. Forensic Toxicol 27:61\u201366","journal-title":"Forensic Toxicol"},{"key":"136_CR4","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1002\/jms.1558","volume":"44","author":"V Auw\u00e4rter","year":"2009","unstructured":"Auw\u00e4rter V, Dresen S, Weinmann W, M\u00fcller M, P\u00fctz M, Ferreir\u00f3s N (2009) \u2018Spice\u2019 and other herbal blends: harmless incense or cannabinoid designer drugs? J Mass Spectrom 44:832\u2013837","journal-title":"J Mass Spectrom"},{"key":"136_CR5","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.forsciint.2009.06.008","volume":"191","author":"R Lindigkeit","year":"2009","unstructured":"Lindigkeit R, Boehme A, Eiserloh I, Luebbecke M, Wiggermann M, Ernst L, Beuerle T (2009) Spice: a never ending story? Forensic Sci Int 191:58\u201363","journal-title":"Forensic Sci Int"},{"key":"136_CR6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.forsciint.2010.01.004","volume":"198","author":"N Uchiyama","year":"2010","unstructured":"Uchiyama N, Kikura-Hanajiri R, Ogata J, Goda Y (2010) Chemical analysis of synthetic cannabinoids as designer drugs in herbal products. Forensic Sci Int 198:31\u201338","journal-title":"Forensic Sci Int"},{"key":"136_CR7","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1002\/jms.1811","volume":"45","author":"S Dresen","year":"2010","unstructured":"Dresen S, Ferreir\u00f3s N, P\u00fctz M, Westphal F, Zimmermann R, Auw\u00e4rter V (2010) Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds. J Mass Spectrom 45:1186\u20131194","journal-title":"J Mass Spectrom"},{"key":"136_CR8","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s11419-010-0100-3","volume":"29","author":"N Uchiyama","year":"2011","unstructured":"Uchiyama N, Kawamura M, Kikura-Hanajiri R, Goda Y (2011) Identification and quantitation of two cannabimimetic phenylacetylindoles JWH-251 and JWH-250, and four cannabimimetic naphthoylindoles JWH-081, JWH-015, JWH-200, and JWH-073 as designer drugs in illegal products. Forensic Toxicol 29:25\u201337","journal-title":"Forensic Toxicol"},{"key":"136_CR9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.legalmed.2011.02.003","volume":"13","author":"R Kikura-Hanajiri","year":"2011","unstructured":"Kikura-Hanajiri R, Uchiyama N, Goda Y (2011) Survey of current trends in the abuse of psychotropic substances and plants in Japan. Legal Med 13:109\u2013115","journal-title":"Legal Med"},{"key":"136_CR10","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1248\/cpb.59.1203","volume":"59","author":"N Uchiyama","year":"2011","unstructured":"Uchiyama N, Kikura-Hanajiri R, Goda Y (2011) Identification of a novel cannabimimetic phenylacetylindole, cannabipiperidiethanone, as a designer drug in a herbal product and its affinity for cannabinoid CB1 and CB2 receptors. Chem Pharm Bull 59:1203\u20131205","journal-title":"Chem Pharm Bull"},{"key":"136_CR11","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11419-011-0108-3","volume":"29","author":"J Nakajima","year":"2011","unstructured":"Nakajima J, Takahashi M, Seto T, Kanai C, Suzuki J, Yoshida M, Hamano T (2011) Identification and quantitation of two benzoylindoles AM-694 and (4-methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone, and three cannabimimetic naphthoylindoles JWH-210, JWH-122, and JWH-019 as adulterants in illegal products obtained via the Internet. Forensic Toxicol 29:95\u2013110","journal-title":"Forensic Toxicol"},{"key":"136_CR12","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1007\/s11419-011-0114-5","volume":"29","author":"J Nakajima","year":"2011","unstructured":"Nakajima J, Takahashi M, Seto T, Kanai C, Suzuki J, Yoshida M, Hamano T (2011) Identification and quantitation of a benzoylindole(2-methoxyphenyl)(1-pentyl-1H-indol-3-yl)methanone and a naphthoylindole 1-(5-fluoropentyl-1H-indol-3-yl)-(naphthalene-1-yl)methanone (AM-2201) found in illegal products obtained via the Internet and their cannabimimetic effects evaluated by in vitro [35S]GTP\u03b3S binding assays. Forensic Toxicol 29:132\u2013141","journal-title":"Forensic Toxicol"},{"key":"136_CR13","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/j.forsciint.2011.03.020","volume":"208","author":"L Ernst","year":"2011","unstructured":"Ernst L, Schiebel HM, Theuring C, Lindigkeit R, Beuerle T (2011) Identification and characterization of JWH-122 used as new ingredient in \u201cSpice-like\u201d herbal incenses. Forensic Sci Int 208:e31\u2013e35","journal-title":"Forensic Sci Int"},{"key":"136_CR14","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/anatox\/35.6.360","volume":"35","author":"M Bononi","year":"2011","unstructured":"Bononi M, Belgi P, Tateo F (2011) Analytical data for identification of the cannabimimetic phenylacetylindole JWH-203. J Anal Toxicol 35:360\u2013363","journal-title":"J Anal Toxicol"},{"key":"136_CR15","unstructured":"EMCDDA (2011) EMCDDA\u2013Europol 2010 Annual Report on the implementation of Council Decision 2005\/387\/JHA EMCDDA-Europol, Lisbon, May 2011. http:\/\/www.emcdda.europa.eu\/attachements.cfm\/att_132857_EN_EMCDDA-Europol%20Annual%20Report%202010A.pdf . Accessed Dec 2011"},{"key":"136_CR16","unstructured":"United Nations Office on Drugs and Crime (UNODC) (2011) Synthetic Cannabinoids in Herbal Products. April 2011. http:\/\/www.unodc.org\/documents\/scientific\/Synthetic_Cannabinoids.pdf . Accessed May 2011"},{"key":"136_CR17","unstructured":"EMCDDA (2011) Online sales of new psychoactive substances\/\u2019legal highs\u2019: summary of results from the 2011 multilingual snapshots., Lisbon, November 2011. http:\/\/www.emcdda.europa.eu\/attachements.cfm\/att_143801_EN_SnapshotSummary.pdf . Accessed Nov 2011"},{"key":"136_CR18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11419-011-0130-5","volume":"30","author":"J Nakajima","year":"2012","unstructured":"Nakajima J, Takahashi M, Seto T, Yoshida M, Kanai C, Suzuki J, Hamano T (2012) Identification and quantitation of two new naphthoylindole drugs-of-abuse, (1-(5-hydroxypentyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone (AM-2202) and (1-(4-pentenyl)-1H-indol-3-yl)(naphthalen-1-yl)methanone, with other synthetic cannabinoids in unregulated \u201cherbal\u201d products circulated in the Tokyo area. Forensic Toxicol 30:33\u201344","journal-title":"Forensic Toxicol"},{"key":"136_CR19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.forsciint.2011.07.011","volume":"214","author":"P Jankovics","year":"2012","unstructured":"Jankovics P, V\u00e1radi A, T\u00f6lgyesi L, Lohner S, N\u00e9meth-Palot\u00e1s J, Balla J (2012) Detection and identification of the new potential synthetic cannabinoids 1-pentyl-3-(2-iodobenzoyl)indole and 1-pentyl-3-(1-adamantoyl)indole in seized bulk powders in Hungary. Forensic Sci Int 214:27\u201332","journal-title":"Forensic Sci Int"},{"key":"136_CR20","first-page":"29","volume":"41","author":"S Kneisel","year":"2011","unstructured":"Kneisel S, Westphal F, Moosmann B, Brecht V, Bisel P, Vidal C, Jacobsen-Bauer A, Bork WR, Auw\u00e4rter V (2011) Cannabimimetics II: mass spectra and ATR-IR spectra of new compounds between the end of 2010 and late 2011. TIAFT Bull 41:29\u201338","journal-title":"TIAFT Bull"},{"key":"136_CR21","doi-asserted-by":"crossref","unstructured":"Grigoryev A, Kavanagh P, Melnik A (2011) The detection of the urinary metabolites of 3-[(adamantan-1-yl)carbonyl]-1-pentylindole (AB-001), a novel cannabimimetic, by gas chromatography-mass spectrometry. Drug Test Anal. doi: 10.1002\/dta.350","DOI":"10.1002\/dta.350"},{"key":"136_CR22","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/978-1-59745-503-9_3","volume-title":"The cannabinoid receptors","author":"JW Huffman","year":"2009","unstructured":"Huffman JW (2009) Cannabimimetic indoles, pyrroles, and indenes: structure-activity relationships and receptor interactions. In: Reggio PH (ed) The cannabinoid receptors. Humana Press, New York, pp 49\u201394"},{"key":"136_CR23","unstructured":"Makriyannis A, Lui Q (2003) Patent: WO\/2003\/035005 May, 2003. Heteroindanes: a new class of potent cannabimimetic ligands"},{"key":"136_CR24","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/sj.bjp.0707303","volume":"151","author":"B Bingham","year":"2007","unstructured":"Bingham B, Jones PG, Uveges AJ, Kotnis S, Lu P, Smith VA, Sun SC, Resnick L, Chlenov M, He Y, Strassle BW, Cummons TA, Piesla MJ, Harrison JE, Whiteside GT, Kennedy JD (2007) Species-specific in vitro pharmacological effects of the cannabinoid receptor 2 (CB2) selective ligand AM1241 and its resolved enantiomers. Br J Pharmacol 151:1061\u20131070","journal-title":"Br J Pharmacol"},{"key":"136_CR25","unstructured":"Makriyannis A, Deng H (2002) Patent: WO\/2002\/060447, August 2002. Receptor selective cannabimimetic aminoalkylindoles"},{"key":"136_CR26","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.1021\/jm0502743","volume":"48","author":"PG Willis","year":"2005","unstructured":"Willis PG, Pavlova OA, Chefer SI, Vaupel DB, Mukhin AG, Horti AG (2005) Synthesis and structure\u2013activity relationship of a novel series of aminoalkylindoles with potential for imaging the neuronal cannabinoid receptor by positron emission tomography. J Med Chem 48:5813\u20135822","journal-title":"J Med Chem"},{"key":"136_CR27","doi-asserted-by":"crossref","first-page":"6386","DOI":"10.1021\/jm050135l","volume":"48","author":"H Deng","year":"2005","unstructured":"Deng H, Gifford AN, Zvonok AM, Cui G, Li X, Fan P, Deschamps JR, Flippen-Anderson JL, Gatley SJ, Makriyannis A (2005) Potent cannabinergic indole analogues as radioiodinatable brain imaging agents for the CB1 cannabinoid receptor. J Med Chem 48:6386\u20136392","journal-title":"J Med Chem"},{"key":"136_CR28","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1097\/FBP.0b013e328349fbd5","volume":"22","author":"TU J\u00e4rbe","year":"2011","unstructured":"J\u00e4rbe TU, Deng H, Vadivel SK, Makriyannis A (2011) Cannabinergic aminoalkylindoles, including AM678\u00a0=\u00a0JWH018 found in \u2018Spice\u2019, examined using drug (\u03949-tetrahydrocannabinol) discrimination for rats. Behav Pharmacol 22:498\u2013507","journal-title":"Behav Pharmacol"},{"key":"136_CR29","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1021\/jm070317a","volume":"50","author":"EK Dziadulewicz","year":"2007","unstructured":"Dziadulewicz EK, Bevan SJ, Brain CT, Coote PR, Culshaw AJ, Davis AJ, Edwards LJ, Fisher AJ, Fox AJ, Gentry C, Groarke A, Hart TW, Huber W, James IF, Kesingland A, La Vecchia L, Loong Y, Lyothier I, McNair K, O\u2019Farrell C, Peacock M, Portmann R, Schopfer U, Yaqoob M, Zadrobilek J (2007) Naphthalen-1-yl-(4-pentyloxynaphthalen-1-yl)methanone: a potent, orally bioavailable human CB1\/CB2 dual agonist with antihyperalgesic properties and restricted central nervous system penetration. J Med Chem 50:3851\u20133856","journal-title":"J Med Chem"},{"key":"136_CR30","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1016\/j.ejmech.2011.01.047","volume":"46","author":"J Liu","year":"2011","unstructured":"Liu J, Obando D, Liao V, Lifa T, Codd R (2011) The many faces of the adamantyl group in drug design. Eur J Med Chem 46:1949\u20131963","journal-title":"Eur J Med Chem"}],"container-title":["Forensic Toxicology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11419-012-0136-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11419-012-0136-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11419-012-0136-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T14:48:46Z","timestamp":1559400526000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11419-012-0136-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4,11]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["136"],"URL":"https:\/\/doi.org\/10.1007\/s11419-012-0136-7","relation":{},"ISSN":["1860-8965","1860-8973"],"issn-type":[{"value":"1860-8965","type":"print"},{"value":"1860-8973","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,4,11]]}}}